Our immediate objective is to identify, characterize, and establish distinct MET SVs, such as GFs and copy gain, as potent precision medicine targets in DMGs.
Previous PostInvestigating the tumorigenesis mechanisms and vulnerabilities of pediatric high-grade gliomas with H3G34R/V
Next PostElucidating Heterogeneity of Resistance Across Molecular Subgroups of Pediatric Ependymomas to Inform Future Therapeutics
Apply to the CBTN Fellowship Program by completing the information below and uploading your one-page project proposal and current CV. Applications are reviewed on a rolling basis.
NOTE: The CBTN Fellowship Program is a research mentorship and engagement opportunity, not a grant or direct funding program.
